The 2nd Annual Traumatic Brain Injury Conference will address the challenges and opportunities in the development of new diagnostics and therapeutics for traumatic brain injury (TBI). Additionally, this conference will highlight strategies for clinical assessment of TBI and will address chronic outcomes of TBI, including post-traumatic stress disorder and neurodegeneration.
Speakers from academia, industry, the military and government will be addressing traumatic brain injury from a variety of perspectives in order to provide attendees with a holistic perspective on the diagnosis, treatment and outcomes associated with traumatic brain injury. To this end, presenters will be addressing the following issues:
- Advances in neuroimaging for TBI
- Clinical trial design for new TBI therapeutics
- Implementation of biomarkers for stratification, outcome prediction and therapeutics intervention monitoring
- Pre-clinical modeling and translating results to the clinic
- Drug delivery (blood-brain barrier) challenges facing development of new therapies
- Treatment of actute as well as post-acute/chronic neurorehabilitation
- Halting secondary injury in TBI
- Cell therapy potential for TBI
- Cognitive measures of TBI and outcomes
- Neuroprotection as a therapeutic intervention
- Regulatory perspectives on clinical trials and companion diagnostic development and commercialization